Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: Final baseline characteristics of the IMPROVE-IT study population
Titel:
Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: Final baseline characteristics of the IMPROVE-IT study population
Auteur:
Blazing, Michael A. Giugliano, Robert P. Cannon, Christopher P. Musliner, Thomas A. Tershakovec, Andrew M. White, Jennifer A. Reist, Craig McCagg, Amy Braunwald, Eugene Califf, Robert M.